vs

Side-by-side financial comparison of Carlyle Group Inc. (CG) and Synopsys (SNPS). Click either name above to swap in a different company.

Synopsys is the larger business by last-quarter revenue ($2.3B vs $1.9B, roughly 1.2× Carlyle Group Inc.). Synopsys runs the higher net margin — 19.9% vs 18.8%, a 1.1% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 50.6%). Synopsys produced more free cash flow last quarter ($605.2M vs $-1.2B). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs 16.9%).

The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

CG vs SNPS — Head-to-Head

Bigger by revenue
SNPS
SNPS
1.2× larger
SNPS
$2.3B
$1.9B
CG
Growing faster (revenue YoY)
CG
CG
+33.6% gap
CG
84.1%
50.6%
SNPS
Higher net margin
SNPS
SNPS
1.1% more per $
SNPS
19.9%
18.8%
CG
More free cash flow
SNPS
SNPS
$1.8B more FCF
SNPS
$605.2M
$-1.2B
CG
Faster 2-yr revenue CAGR
CG
CG
Annualised
CG
66.2%
16.9%
SNPS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CG
CG
SNPS
SNPS
Revenue
$1.9B
$2.3B
Net Profit
$358.1M
$448.7M
Gross Margin
71.0%
Operating Margin
24.3%
5.4%
Net Margin
18.8%
19.9%
Revenue YoY
84.1%
50.6%
Net Profit YoY
69.8%
-59.7%
EPS (diluted)
$0.96
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CG
CG
SNPS
SNPS
Q4 25
$1.9B
$2.3B
Q3 25
$332.7M
$1.7B
Q2 25
$1.6B
$1.6B
Q1 25
$973.1M
$1.5B
Q4 24
$1.0B
$1.5B
Q3 24
$2.6B
$1.5B
Q2 24
$1.1B
$1.5B
Q1 24
$688.4M
$1.6B
Net Profit
CG
CG
SNPS
SNPS
Q4 25
$358.1M
$448.7M
Q3 25
$900.0K
$242.5M
Q2 25
$319.7M
$345.3M
Q1 25
$130.0M
$295.7M
Q4 24
$210.9M
$1.1B
Q3 24
$595.7M
$408.1M
Q2 24
$148.2M
$292.1M
Q1 24
$65.6M
$449.1M
Gross Margin
CG
CG
SNPS
SNPS
Q4 25
71.0%
Q3 25
78.1%
Q2 25
80.2%
Q1 25
81.4%
Q4 24
78.3%
Q3 24
80.9%
Q2 24
79.4%
Q1 24
80.0%
Operating Margin
CG
CG
SNPS
SNPS
Q4 25
24.3%
5.4%
Q3 25
25.8%
9.5%
Q2 25
28.0%
23.5%
Q1 25
17.6%
17.3%
Q4 24
25.7%
20.3%
Q3 24
29.9%
23.6%
Q2 24
20.5%
22.8%
Q1 24
17.5%
21.8%
Net Margin
CG
CG
SNPS
SNPS
Q4 25
18.8%
19.9%
Q3 25
0.3%
13.9%
Q2 25
20.3%
21.5%
Q1 25
13.4%
20.3%
Q4 24
20.4%
74.4%
Q3 24
22.6%
26.7%
Q2 24
13.9%
20.1%
Q1 24
9.5%
27.2%
EPS (diluted)
CG
CG
SNPS
SNPS
Q4 25
$0.96
$2.44
Q3 25
$0.00
$1.50
Q2 25
$0.87
$2.21
Q1 25
$0.35
$1.89
Q4 24
$0.56
$7.13
Q3 24
$1.63
$2.61
Q2 24
$0.40
$1.88
Q1 24
$0.18
$2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CG
CG
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$2.0B
$3.0B
Total DebtLower is stronger
$13.5B
Stockholders' EquityBook value
$7.1B
$28.3B
Total Assets
$29.1B
$48.2B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CG
CG
SNPS
SNPS
Q4 25
$2.0B
$3.0B
Q3 25
$2.2B
$2.6B
Q2 25
$1.3B
$14.3B
Q1 25
$1.2B
$3.8B
Q4 24
$1.3B
$4.1B
Q3 24
$1.4B
$2.0B
Q2 24
$914.8M
$1.7B
Q1 24
$1.3B
$1.3B
Total Debt
CG
CG
SNPS
SNPS
Q4 25
$13.5B
Q3 25
$14.3B
Q2 25
$10.1B
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CG
CG
SNPS
SNPS
Q4 25
$7.1B
$28.3B
Q3 25
$6.8B
$27.6B
Q2 25
$6.7B
$9.9B
Q1 25
$6.4B
$9.3B
Q4 24
$6.3B
$9.0B
Q3 24
$6.3B
$7.7B
Q2 24
$5.7B
$7.2B
Q1 24
$5.7B
$6.7B
Total Assets
CG
CG
SNPS
SNPS
Q4 25
$29.1B
$48.2B
Q3 25
$27.1B
$48.2B
Q2 25
$25.1B
$23.8B
Q1 25
$24.1B
$13.0B
Q4 24
$23.1B
$13.1B
Q3 24
$22.7B
$11.6B
Q2 24
$22.3B
$11.0B
Q1 24
$20.8B
$10.6B
Debt / Equity
CG
CG
SNPS
SNPS
Q4 25
0.48×
Q3 25
0.52×
Q2 25
1.01×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CG
CG
SNPS
SNPS
Operating Cash FlowLast quarter
$-1.2B
$639.7M
Free Cash FlowOCF − Capex
$-1.2B
$605.2M
FCF MarginFCF / Revenue
-65.1%
26.8%
Capex IntensityCapex / Revenue
2.2%
1.5%
Cash ConversionOCF / Net Profit
-3.34×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$-3.4B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CG
CG
SNPS
SNPS
Q4 25
$-1.2B
$639.7M
Q3 25
$-1.6B
$671.0M
Q2 25
$-168.8M
$275.4M
Q1 25
$-352.1M
$-67.5M
Q4 24
$-352.8M
$562.8M
Q3 24
$791.9M
$455.4M
Q2 24
$-1.3B
$476.6M
Q1 24
$71.1M
$-87.8M
Free Cash Flow
CG
CG
SNPS
SNPS
Q4 25
$-1.2B
$605.2M
Q3 25
$-1.6B
$632.4M
Q2 25
$-186.3M
$219.8M
Q1 25
$-368.8M
$-108.2M
Q4 24
$-379.5M
$558.4M
Q3 24
$772.8M
$415.4M
Q2 24
$-1.3B
$438.2M
Q1 24
$56.9M
$-128.2M
FCF Margin
CG
CG
SNPS
SNPS
Q4 25
-65.1%
26.8%
Q3 25
-475.7%
36.3%
Q2 25
-11.8%
13.7%
Q1 25
-37.9%
-7.4%
Q4 24
-36.8%
37.3%
Q3 24
29.3%
27.2%
Q2 24
-120.4%
30.1%
Q1 24
8.3%
-7.8%
Capex Intensity
CG
CG
SNPS
SNPS
Q4 25
2.2%
1.5%
Q3 25
7.0%
2.2%
Q2 25
1.1%
3.5%
Q1 25
1.7%
2.8%
Q4 24
2.6%
0.3%
Q3 24
0.7%
2.6%
Q2 24
1.7%
2.6%
Q1 24
2.1%
2.4%
Cash Conversion
CG
CG
SNPS
SNPS
Q4 25
-3.34×
1.43×
Q3 25
-1732.78×
2.77×
Q2 25
-0.53×
0.80×
Q1 25
-2.71×
-0.23×
Q4 24
-1.67×
0.51×
Q3 24
1.33×
1.12×
Q2 24
-8.57×
1.63×
Q1 24
1.08×
-0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CG
CG

Fund Management Fee$606.8M32%
Other$528.7M28%
Global Private Equity Segment$307.3M16%
Global Credit Segment$238.0M13%
Carlyle Alp Invest Segment$124.6M7%
Incentive Fee$55.4M3%
Fee Related Performance Revenues$29.2M2%
Investment Advice$11.1M1%

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons